Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) EBT Margin (2020 - 2025)

Foghorn Therapeutics (FHTX) has 5 years of EBT Margin data on record, last reported at 682.88% in Q4 2024.

  • For Q4 2024, EBT Margin fell 29945.0% year-over-year to 682.88%; the TTM value through Dec 2024 reached 383.24%, down 10744.0%, while the annual FY2024 figure was 383.24%, 10744.0% down from the prior year.
  • EBT Margin reached 682.88% in Q4 2024 per FHTX's latest filing, down from 244.9% in the prior quarter.
  • Across five years, EBT Margin topped out at 77.85% in Q3 2023 and bottomed at 65268.29% in Q3 2021.
  • Average EBT Margin over 5 years is 6141.79%, with a median of 645.59% recorded in 2022.
  • Peak YoY movement for EBT Margin: tumbled -5482639bps in 2021, then surged 6487985bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 8406.37% in 2020, then soared by 52bps to 3998.32% in 2021, then skyrocketed by 83bps to 690.39% in 2022, then skyrocketed by 44bps to 383.43% in 2023, then crashed by -78bps to 682.88% in 2024.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 682.88% in Q4 2024, 244.9% in Q3 2024, and 333.61% in Q2 2024.